Advances with Long Non-Coding RNAs in Alzheimer’s Disease as Peripheral Biomarker

One of the most compelling needs in the study of Alzheimer’s disease (AD) is the characterization of cognitive decline peripheral biomarkers. In this context, the theme of altered RNA processing has emerged as a contributing factor to AD. In particular, the significant role of long non-coding RNAs (lncRNAs) associated to AD is opening new perspectives in AD research. This class of RNAs may offer numerous starting points for new investigations about pathogenic mechanisms and, in particular, about peripheral biomarkers. Indeed, altered lncRNA signatures are emerging as potential diagnostic biomarkers. In this review, we have collected and fully explored all the presented data about lncRNAs and AD in the peripheral system to offer an overview about this class of non-coding RNAs and their possible role in AD.

[1]  Xiong Wang,et al.  The emerging role of non-coding RNAs from extracellular vesicles in Alzheimer's disease. , 2021, Journal of integrative neuroscience.

[2]  Maite Huarte,et al.  Gene regulation by long non-coding RNAs and its biological functions , 2020, Nature reviews. Molecular cell biology.

[3]  M. Bordoni,et al.  Alzheimer’s, Parkinson’s Disease and Amyotrophic Lateral Sclerosis Gene Expression Patterns Divergence Reveals Different Grade of RNA Metabolism Involvement , 2020, International journal of molecular sciences.

[4]  Xingyu Chen,et al.  Long noncoding RNA MALAT1 and its target microRNA-125b are potential biomarkers for Alzheimer's disease management via interactions with FOXQ1, PTGS2 and CDK5. , 2020, American journal of translational research.

[5]  A. Tomatir,et al.  Altered Expression of Long Non-coding RNAs in Peripheral Blood Mononuclear Cells of Patients with Alzheimer’s Disease , 2020, Molecular Neurobiology.

[6]  X. Bian,et al.  Elevated plasma levels of exosomal BACE1-AS combined with the volume and thickness of the right entorhinal cortex may serve as a biomarker for the detection of Alzheimer's disease , 2020, Molecular medicine reports.

[7]  Ana Emília Goulart Lemos,et al.  The long non-coding RNA PCA3: an update of its functions and clinical applications as a biomarker in prostate cancer , 2019, Oncotarget.

[8]  Hong Wang,et al.  Knockdown of lncRNA SNHG1 attenuated Aβ25-35-inudced neuronal injury via regulating KREMEN1 by acting as a ceRNA of miR-137 in neuronal cells. , 2019, Biochemical and biophysical research communications.

[9]  Xiao Zhang,et al.  The effect of BACE1-AS on β-amyloid generation by regulating BACE1 mRNA expression , 2019, BMC Molecular Biology.

[10]  M. Talebi,et al.  Long Non-coding RNA BACE1-AS May Serve as an Alzheimer’s Disease Blood-Based Biomarker , 2019, Journal of Molecular Neuroscience.

[11]  J. Tan,et al.  Long Noncoding RNA NEAT1 Aggravates Aβ-Induced Neuronal Damage by Targeting miR-107 in Alzheimer's Disease , 2019, Yonsei medical journal.

[12]  M. Valis,et al.  MicroRNAs in Alzheimer’s Disease: Diagnostic Markers or Therapeutic Agents? , 2019, Front. Pharmacol..

[13]  D. Waddell,et al.  Ttc39c is upregulated during skeletal muscle atrophy and modulates ERK1/2 MAP kinase and hedgehog signaling , 2019, Journal of cellular physiology.

[14]  F. Fang,et al.  Long non-coding RNA MALAT1 Inhibits Neuron Apoptosis and Neuroinflammation while Stimulates Neurite Outgrowth and its Correlation with MiR-125b Mediated PTGS2, CDK5 and FOXQ1 in Alzheimer's Disease. , 2019, Current Alzheimer research.

[15]  Ravi S Muddashetty,et al.  Emerging Role of microRNAs in Dementia. , 2019, Journal of molecular biology.

[16]  Y. Zhang,et al.  Exosomes: biogenesis, biologic function and clinical potential , 2019, Cell & Bioscience.

[17]  T. Zhou,et al.  Suppression of lncRNA-ATB prevents amyloid-β-induced neurotoxicity in PC12 cells via regulating miR-200/ZNF217 axis. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[18]  Jing Xu,et al.  Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines , 2018, Journal of Extracellular Vesicles.

[19]  S. Lehrer.  Glioma and Alzheimer’s Disease , 2018, Journal of Alzheimer's disease reports.

[20]  Zhen Yang,et al.  LncRNADisease 2.0: an updated database of long non-coding RNA-associated diseases , 2018, Nucleic Acids Res..

[21]  Cheng-Long Xie,et al.  Plasma long non-coding RNA BACE1 as a novel biomarker for diagnosis of Alzheimer disease , 2018, BMC Neurology.

[22]  Michael Q. Zhang,et al.  NONCODEV5: a comprehensive annotation database for long non-coding RNAs , 2017, Nucleic Acids Res..

[23]  Jordan A. Ramilowski,et al.  An atlas of human long non-coding RNAs with accurate 5′ ends , 2017, Nature.

[24]  Jin Yao,et al.  Long non‐coding RNA MALAT1 regulates retinal neurodegeneration through CREB signaling , 2016, EMBO molecular medicine.

[25]  Kevin V. Morris,et al.  Extracellular vesicle associated long non-coding RNAs functionally enhance cell viability , 2016, Non-coding RNA research.

[26]  B. Zhao,et al.  Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a , 2016, Journal of experimental & clinical cancer research : CR.

[27]  Xiaolin Zhou,et al.  Identification of Alzheimer's disease–associated long noncoding RNAs , 2015, Neurobiology of Aging.

[28]  Y. Gui,et al.  Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease , 2015, Oncotarget.

[29]  S. Hill,et al.  Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies , 2015, PloS one.

[30]  L. O’Driscoll,et al.  Biological properties of extracellular vesicles and their physiological functions , 2015, Journal of extracellular vesicles.

[31]  Te Liu,et al.  Attenuated ability of BACE1 to cleave the amyloid precursor protein via silencing long noncoding RNA BACE1-AS expression , 2014, Molecular medicine reports.

[32]  F. Liu,et al.  A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.

[33]  Hagai Bergman,et al.  Long Non-Coding RNA and Alternative Splicing Modulations in Parkinson's Leukocytes Identified by RNA Sequencing , 2014, PLoS Comput. Biol..

[34]  D. Holtzman,et al.  Lysosomal Sorting of Amyloid-β by the SORLA Receptor Is Impaired by a Familial Alzheimer’s Disease Mutation , 2014, Science Translational Medicine.

[35]  T. Willnow,et al.  Sorting receptor SORLA – a trafficking path to avoid Alzheimer disease , 2013, Journal of Cell Science.

[36]  H. Ye,et al.  MicroRNA-98 induces an Alzheimer’s disease-like disturbance by targeting insulin-like growth factor 1 , 2013, Neuroscience Bulletin.

[37]  R. Young,et al.  Transcriptional Regulation and Its Misregulation in Disease , 2013, Cell.

[38]  J. Kjems,et al.  Natural RNA circles function as efficient microRNA sponges , 2013, Nature.

[39]  R. Cancedda,et al.  NDM29, a RNA polymerase III-dependent non coding RNA, promotes amyloidogenic processing of APP and amyloid β secretion. , 2012, Biochimica et biophysica acta.

[40]  P. la Colla,et al.  Changes in cholesterol metabolism-related gene expression in peripheral blood mononuclear cells from Alzheimer patients , 2012, Lipids in Health and Disease.

[41]  Wei Chen,et al.  The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease. , 2012, Toxicology letters.

[42]  Qing-Rong Liu,et al.  Identification of Novel GDNF Isoforms and cis-Antisense GDNFOS Gene and Their Regulation in Human Middle Temporal Gyrus of Alzheimer Disease* , 2011, The Journal of Biological Chemistry.

[43]  Michael Q. Zhang,et al.  A long nuclear‐retained non‐coding RNA regulates synaptogenesis by modulating gene expression , 2010, EMBO Journal.

[44]  M. Weiner,et al.  Cerebrospinal fluid and plasma biomarkers in Alzheimer disease , 2010, Nature Reviews Neurology.

[45]  Guojun Bu,et al.  Apolipoprotein E and its receptors in Alzheimer's disease: pathways, pathogenesis and therapy , 2009, Nature Reviews Neuroscience.

[46]  T. Morgan,et al.  Expression of a noncoding RNA is elevated in Alzheimer's disease and drives rapid feed-forward regulation of β-secretase , 2008, Nature Medicine.

[47]  B. Hyman,et al.  Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Levey,et al.  Loss of apolipoprotein E receptor LR11 in Alzheimer disease. , 2004, Archives of neurology.

[49]  R. Akhter.  Circular RNA and Alzheimer's Disease. , 2018, Advances in experimental medicine and biology.

[50]  D. Hou,et al.  Plasma long noncoding RNA 51 A as a stable biomarker of Alzheimer ’ s disease , 2017 .

[51]  D. Selkoe.  Alzheimer's disease. , 2011, Cold Spring Harbor perspectives in biology.

[52]  Pang-Ning Tan,et al.  Receiver Operating Characteristic , 2009, Encyclopedia of Database Systems.

[53]  W. Maetzler,et al.  Glial cell-line derived neurotrophic factor (GDNF) concentrations in cerebrospinal fluid and serum of patients with early Alzheimer's disease and normal controls. , 2009, Journal of Alzheimer's disease : JAD.